Iressa Effective in Initial Treatment of Subset of Lung Cancer Patients
July 17th, 2006
According to the results of a small phase II clinical trial conducted in Japan, Iressa? (gefitinib) may have a role in the initial treatment of advanced lung cancer patients who have EGFR gene mutations. These results were published in the Journal of Clinical Oncology.